Location: Dallas, TX
CIK: 0001791827 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value: $1.96B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BSX | BOSTON SCIENTIFIC CORP | 962,000 | $80.62M | 4.1% | $49.10 | +60.6% | COM | 101137107 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,917,231 | $79.87M | 4.1% | $18.09 | +54.0% | COM | 252828108 |
| ISRG | INTUITIVE SURGICAL INC | 148,200 | $72.81M | 3.7% | $351.77 | +32.3% | COM NEW | 46120E602 |
| NTRA | NATERA INC | 556,400 | $70.63M | 3.6% | $55.01 | +108.7% | COM | 632307104 |
| CGON | CG ONCOLOGY INC | 1,656,000 | $62.48M | 3.2% | $39.58 | -11.4% | COM | 156944100 |
| ACHC | ACADIA HEALTHCARE COMPANY IN | 985,000 | $62.46M | 3.2% | $72.97 | -1.1% | COM | 00404A109 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 460,000 | $53M | 2.7% | $96.63 | +41.9% | COM | 64125C109 |
| UNH | UNITEDHEALTH GROUP INC | 87,400 | $51.1M | 2.6% | $548.30 | 0.0% | COM | 91324P102 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 431,000 | $48.02M | 2.4% | $142.84 | -23.3% | SHS USD | G50871105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,455,000 | $47.26M | 2.4% | $18.49 | +11.7% | COM | 87164F105 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 3,444,002 | $45.98M | 2.3% | $14.32 | -7.1% | COM NEW | 46489V302 |
| GKOS | GLAUKOS CORP | 344,900 | $44.93M | 2.3% | $101.65 | +22.4% | COM | 377322102 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,373,000 | $43.5M | 2.2% | $26.67 | +42.2% | COM | 45166A102 |
| INSM | INSMED INC | 592,000 | $43.22M | 2.2% | $48.37 | +52.6% | COM PAR $.01 | 457669307 |
| TMO | THERMO FISHER SCIENTIFIC INC | 68,600 | $42.43M | 2.2% | $529.04 | +11.4% | COM | 883556102 |
| THC | TENET HEALTHCARE CORP | 253,000 | $42.05M | 2.1% | $51.02 | +196.4% | COM NEW | 88033G407 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 752,000 | $41.77M | 2.1% | $51.17 | -0.5% | COM | 90400D108 |
| HUM | HUMANA INC | 129,700 | $41.08M | 2.1% | $348.89 | 0.0% | COM | 444859102 |
| EXAS | EXACT SCIENCES CORP | 588,000 | $40.05M | 2.0% | $55.62 | +1.5% | COM | 30063P105 |
| ILMN | ILLUMINA INC | 292,000 | $38.08M | 1.9% | $133.40 | -7.5% | COM | 452327109 |
| ARVN | ARVINAS INC | 1,497,000 | $36.87M | 1.9% | $47.79 | -45.4% | COM | 04335A105 |
| RVMD | REVOLUTION MEDICINES INC | 790,000 | $35.83M | 1.8% | $30.74 | +41.6% | COM | 76155X100 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,132,000 | $34.09M | 1.7% | $15.99 | — | SPONSORED ADS | 152309100 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1,804,493 | $32.63M | 1.7% | $20.69 | -32.5% | COM | 71722W107 |
| XENE | XENON PHARMACEUTICALS INC | 818,000 | $32.2M | 1.6% | $37.48 | +7.6% | COM | 98420N105 |
| AVTR | AVANTOR INC | 1,235,000 | $31.95M | 1.6% | $21.56 | +13.9% | COM | 05352A100 |
| — | BLUEPRINT MEDICINES CORP | 315,000 | $29.14M | 1.5% | $57.39 | — | COM | 09627Y109 |
| MIRM | MIRUM PHARMACEUTICALS INC | 731,104 | $28.51M | 1.5% | $27.38 | +45.7% | COM | 604749101 |
| SGRY | SURGERY PARTNERS INC | 827,000 | $26.66M | 1.4% | $28.11 | +5.0% | COM | 86881A100 |
| AXSM | AXSOME THERAPEUTICS INC | 296,100 | $26.61M | 1.4% | $55.95 | +56.0% | COM | 05464T104 |
| DHR | DANAHER CORPORATION | 95,000 | $26.41M | 1.3% | $217.74 | +20.5% | COM | 235851102 |
| JANX | JANUX THERAPEUTICS INC | 562,000 | $25.53M | 1.3% | $35.44 | +22.8% | COM | 47103J105 |
| NMRA | NEUMORA THERAPEUTICS INC. | 1,800,000 | $23.78M | 1.2% | $12.81 | -9.0% | COM | 640979100 |
| KYMR | KYMERA THERAPEUTICS INC | 500,000 | $23.66M | 1.2% | $44.16 | 0.0% | COM | 501575104 |
| BHVN | BIOHAVEN LTD | 465,000 | $23.24M | 1.2% | $35.42 | +9.8% | COM | G1110E107 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 320,000 | $22.49M | 1.1% | $83.59 | 0.0% | COM | 09061G101 |
| ARGX | ARGENX SE | 38,200 | $20.71M | 1.1% | $430.04 | — | SPONSORED ADR | 04016X101 |
| INCY | INCYTE CORP | 308,110 | $20.37M | 1.0% | $56.64 | +12.6% | COM | 45337C102 |
| ABBV | ABBVIE INC | 100,000 | $19.75M | 1.0% | $139.64 | +28.0% | COM | 00287Y109 |
| ORKA | ORUKA THERAPEUTICS INC | 790,926 | $19.39M | 1.0% | $34.79 | 0.0% | COM | 687604108 |
| GPCR | STRUCTURE THERAPEUTICS INC | 430,900 | $18.91M | 1.0% | $43.81 | — | SPONSORED ADS | 86366E106 |
| NGNE | NEUROGENE INC | 425,041 | $17.83M | 0.9% | $21.87 | +77.3% | COM | 64135M105 |
| TERN | TERNS PHARMACEUTICALS INC | 2,133,872 | $17.8M | 0.9% | $8.23 | 0.0% | COM | 880881107 |
| ASND | ASCENDIS PHARMA A/S | 119,000 | $17.77M | 0.9% | $149.31 | — | SPONSORED ADR | 04351P101 |
| BNTX | BIONTECH SE | 145,000 | $17.22M | 0.9% | $118.77 | — | SPONSORED ADS | 09075V102 |
| — | INTRA-CELLULAR THERAPIES INC | 233,000 | $17.05M | 0.9% | $52.09 | — | COM | 46116X101 |
| KROS | KEROS THERAPEUTICS INC | 293,200 | $17.03M | 0.9% | $57.13 | -13.6% | COM | 492327101 |
| DXCM | DEXCOM INC | 240,000 | $16.09M | 0.8% | $125.93 | -34.8% | COM | 252131107 |
| ORIC | ORIC PHARMACEUTICALS INC | 1,447,119 | $14.83M | 0.8% | $9.89 | 0.0% | COM | 68622P109 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 889,700 | $14.77M | 0.8% | $19.16 | -9.7% | ORDINARY SHARES | N62509109 |
| CNTX | CONTEXT THERAPEUTICS INC | 7,417,155 | $14.54M | 0.7% | $1.72 | +28.7% | COM | 21077P108 |
| ZTS | ZOETIS INC | 71,000 | $13.87M | 0.7% | $181.33 | 0.0% | CL A | 98978V103 |
| RCKT | ROCKET PHARMACEUTICALS INC | 749,000 | $13.83M | 0.7% | $19.03 | +7.6% | COM | 77313F106 |
| IMUX | IMMUNIC INC | 8,266,000 | $13.64M | 0.7% | $1.30 | +9.6% | COM | 4525EP101 |
| BMY | BRISTOL-MYERS SQUIBB CO | 263,000 | $13.61M | 0.7% | $43.65 | 0.0% | COM | 110122108 |
| IMNM | IMMUNOME INC | 873,891 | $12.78M | 0.7% | $8.31 | +70.9% | COM | 45257U108 |
| RGNX | REGENXBIO INC | 1,132,564 | $11.88M | 0.6% | $17.79 | -31.5% | COM | 75901B107 |
| COGT | COGENT BIOSCIENCES INC | 1,001,000 | $10.81M | 0.6% | $6.96 | +39.9% | COM | 19240Q201 |
| APGE | APOGEE THERAPEUTICS INC | 154,000 | $9.046M | 0.5% | $44.68 | +7.2% | COM | 03770N101 |
| PRVA | PRIVIA HEALTH GROUP INC | 466,800 | $8.5M | 0.4% | $26.12 | -26.9% | COM | 74276R102 |
| HELP | CYBIN INC | 918,000 | $8.161M | 0.4% | $9.89 | 0.0% | COM NEW | 23256X407 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 169,000 | $7.313M | 0.4% | $46.24 | -6.0% | COM | G31249108 |
| CGEM | CULLINAN THERAPEUTICS INC | 425,000 | $7.114M | 0.4% | $21.29 | -16.7% | COM | 230031106 |
| IMCR | IMMUNOCORE HLDGS PLC | 200,000 | $6.226M | 0.3% | $41.38 | — | ADS | 45258D105 |
| DYN | DYNE THERAPEUTICS INC | 165,000 | $5.927M | 0.3% | $39.80 | 0.0% | COM | 26818M108 |
| SNY | SANOFI | 100,000 | $5.763M | 0.3% | $48.52 | — | SPONSORED ADR | 80105N105 |
| EDIT | EDITAS MEDICINE INC | 1,465,000 | $4.996M | 0.3% | $5.07 | -14.1% | COM | 28106W103 |
| TMDX | TRANSMEDICS GROUP INC | 27,600 | $4.333M | 0.2% | $154.09 | 0.0% | COM | 89377M109 |
| — | KEZAR LIFE SCIENCES INC | 5,026,000 | $3.886M | 0.2% | $12.16 | — | COM | 49372L100 |
| QURE | UNIQURE NV | 673,618 | $3.321M | 0.2% | $6.51 | 0.0% | SHS | N90064101 |
| IMVT | IMMUNOVANT INC | 99,000 | $2.822M | 0.1% | $27.93 | +5.6% | COM | 45258J102 |
| ANRO | ALTO NEUROSCIENCE INC | 240,000 | $2.746M | 0.1% | $12.24 | 0.0% | COM SHS | 02157Q109 |
| PRME | PRIME MEDICINE INC | 694,000 | $2.686M | 0.1% | $7.58 | -38.9% | COM | 74168J101 |
| SYRS | SYROS PHARMACEUTICALS INC | 1,063,000 | $2.285M | 0.1% | $5.92 | -39.3% | COM NEW | 87184Q206 |
| SCYX | SCYNEXIS INC | 1,448,728 | $2.159M | 0.1% | $2.82 | -37.4% | COM NEW | 811292200 |
| TIL | INSTIL BIO INC | 29,100 | $1.959M | 0.1% | $23.54 | 0.0% | COM NEW | 45783C200 |
| PRLD | PRELUDE THERAPEUTICS INC | 890,000 | $1.842M | 0.1% | $4.63 | 0.0% | COM | 74065P101 |
| — | KARYOPHARM THERAPEUTICS INC | 2,018,500 | $1.675M | 0.1% | $3.40 | — | COM | 48576U106 |
| HYPR | HYPERFINE INC | 1,188,178 | $1.283M | 0.1% | $9.78 | -89.1% | COM CL A | 44916K106 |
| — | BLUEBIRD BIO INC | 1,631,143 | $847K | 0.0% | $0.52 | — | COM | 09609G100 |
| — | CAREMAX INC | 21,200 | $36,040 | 0.0% | $4.82 | — | CL A NEW | 14171W202 |